Showing 1 posts of 1 posts found.
Pfizer has again slimmed down its product pipeline as the US giant looks to cut R&D spending and sharpen its …
PhaSER secures $2.7m Gates Foundation renewal for neglected disease drug research
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
Europa Biosite enters Czech market with acquisition of diagnostics distributor
Qureight paper argues for fibrosis extent as imaging biomarker in lung disease trials